UTHR insider transactions
United Therapeutics Corporation (UTHR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for UTHR
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $5,476,462 worth of shares (9,500 units at $576.47) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,689,051 worth of shares (8,300 units at $564.95) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $1,056,425 worth of shares (1,920 units at $550.22) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $3,926,177 worth of shares (7,580 units at $517.97) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,535,480 worth of shares (9,500 units at $477.42) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $117.76 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,568,106 worth of shares (9,500 units at $480.85) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,523,635 worth of shares (9,500 units at $476.17) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,498,753 worth of shares (9,500 units at $473.55) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $117.76 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,669,918 worth of shares (9,500 units at $491.57) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,700,851 worth of shares (9,500 units at $494.83) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,698,271 worth of shares (9,500 units at $494.55) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,700,505 worth of shares (9,500 units at $494.79) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,712,580 worth of shares (9,500 units at $496.06) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,129,608 worth of shares (8,300 units at $497.54) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,763,172 worth of shares (9,500 units at $501.39) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $117.76 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,765,119 worth of shares (9,500 units at $501.59) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,789,152 worth of shares (9,500 units at $504.12) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Mesa Nilda exercised 130 shares at a strike of $110.86 and sold $115,338 worth of shares (228 units at $505.87), decreasing direct ownership by 13% to 5,580 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,757,773 worth of shares (9,500 units at $500.82) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,772,295 worth of shares (9,500 units at $502.35) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,767,467 worth of shares (9,500 units at $501.84) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,740,795 worth of shares (9,500 units at $499.03) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $117.76 and sold $4,647,354 worth of shares (9,500 units at $489.20) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by United Therapeutics Corporation4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A sold $4,000,836 worth of shares (8,300 units at $482.03) as part of a pre-agreed trading plan and exercised 8,300 shares at a strike of $146.03 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,883,839 worth of shares (9,500 units at $514.09) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,855,312 worth of shares (9,500 units at $511.09) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,916,363 worth of shares (9,500 units at $517.51) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,964,376 worth of shares (9,500 units at $522.57) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,914,190 worth of shares (9,500 units at $517.28) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,918,273 worth of shares (9,500 units at $517.71) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,863,730 worth of shares (9,500 units at $511.97) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,924,666 worth of shares (9,500 units at $518.39) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,949,717 worth of shares (9,500 units at $521.02) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,342,079 worth of shares (8,300 units at $523.14) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,006,104 worth of shares (9,500 units at $526.96) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,898,221 worth of shares (9,500 units at $515.60) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,812,568 worth of shares (9,500 units at $506.59) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,739,664 worth of shares (9,500 units at $498.91) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,790,316 worth of shares (9,500 units at $504.24) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,892,748 worth of shares (9,500 units at $515.03) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,967,292 worth of shares (9,500 units at $522.87) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,036,073 worth of shares (9,500 units at $530.11) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,048,137 worth of shares (9,500 units at $531.38) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,990,873 worth of shares (9,500 units at $525.36) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A sold $4,291,512 worth of shares (8,300 units at $517.05) as part of a pre-agreed trading plan and exercised 8,300 shares at a strike of $146.03 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,927,985 worth of shares (9,500 units at $518.74) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,912,310 worth of shares (9,500 units at $517.09) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,902,569 worth of shares (9,500 units at $516.06) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,930,098 worth of shares (9,500 units at $518.96) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,986,594 worth of shares (9,500 units at $524.90) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)